Subscribe To
Angle says study shows parsortix can select patients most suitable for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Pa...
January 21, 2022, 3:30 am
Angle says study shows parsortix can select patients most suitable for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Pa...
January 21, 2022, 3:30 am
Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its...
January 21, 2022, 2:59 am
Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its...
January 21, 2022, 2:59 am
Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its...
January 21, 2022, 2:59 am
Clovis oncology is now discounted and offers a great risk-reward
Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...
December 30, 2021, 1:17 pm
Clovis oncology is now discounted and offers a great risk-reward
Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...
December 30, 2021, 1:17 pm
Clovis oncology is now discounted and offers a great risk-reward
Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...
December 30, 2021, 1:17 pm
Why immunogen stock is flying high today
The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cance...
December 1, 2021, 1:25 pm
Why immunogen stock is flying high today
The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cance...
December 1, 2021, 1:25 pm
Why immunogen stock is flying high today
The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cance...
December 1, 2021, 1:25 pm
Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial
Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escala...
October 7, 2021, 3:29 pm
Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial
Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escala...
October 7, 2021, 3:29 pm
Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial
Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escala...
October 7, 2021, 3:29 pm